Indeed, the discovery of GLP‐1 and its receptors has been fundamental for the generation of the most successful drugs to curb obesity, type II diabetes and potentially other metabolic‐related disorders like kidney and cardiovascular disease.16, 17. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.